Delivery Order SPE2DB20D3505-SPE2DB25FYCCK
Award Date 9/2/25
Potential Completion Date 9/3/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Posaconazole DR 100 mg tablets (60-count units) with a ceiling value of $1,199.24. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to complete by December 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,056.58 to AmerisourceBergen Drug Corp for the supply of Posaconazole 300 mg/16.7 mL vials on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger...
- This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568700372 Posaconazole DR 100 mg Tablet 60s, a pharmaceutical product. The contract has a ceiling value of $3,073.39 and is a firm fixed price delivery order. The contract has an ultimate completion date of July 3, 2025. This contract is not set-aside and is open to...
- This federal contract award is for the delivery of Posaconazole delayed-release 100 mg tablets, in quantities of 60, to the Defense Logistics Agency (DLA) Troop Support Medical division. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, which has a for-profit business structure. The contract is a firm fixed price delivery order with a potential value of $1,651.08. The award does not utilize any set-aside...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,263.06 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 60 posaconazole 100 mg tablets. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 14, 2023. No set-aside designation was applied to this order placed pursuant to DLA's pharmaceutical supply contracts. Amerisourcebergen routinely provides...
- This federal contract award is for the delivery of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,681.28 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 3, 2025 and was awarded on February 28, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency awarded a delivery order valued at $10,612.09 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order represents a non-competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,954.56 for ORSERDU 345 mg tablets (30-count) on October 20, 2025, with completion scheduled for November 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $18,339.50 on July 18, 2025, with an ultimate completion date of July 21, 2025. The award is for Gemtesa 75 mg tablets in a quantity of 90 units under a firm fixed price contract type with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 25, 2025, for $37,329.65 to supply Dovato 50-300 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order is funded through the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 26, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's...